scholarly journals Comparative retrospective evaluation of efficacy of rituximab therapy with dexamethasone cyclophosphamide pulse therapy in patients of pemphigus vulgaris at a tertiary care hospital

2020 ◽  
Vol 13 (2) ◽  
pp. 120
Author(s):  
ArunKumar Yadav ◽  
Preema Sinha ◽  
Bhavni Oberoi ◽  
Vikas Pathania ◽  
DurgaMadhab Tripathy
2021 ◽  
pp. 52-54
Author(s):  
Jashandeep Kaur ◽  
Tejinder Kaur ◽  
Shaminder Singh Dhillon

Pemphigus vulgaris is the most common autoimmune blistering disorder and the prevalence varies from 0.18 to 6.96 cases per 1,00,000 population worldwide [3].Pulse therapy with high doses of Corticosterids and Cyclophosphamide (most commonly Dexamethasone Cyclophosphamide Pulse (DCP)) for the treatment of pemphigus remained mainstay therapy for past few decades. Targeted immuno-modulation is becoming popular with advent of biological therapies like Rituximab due to lower side effects but its cost is a limiting factor. There is a little literature available on comparison of cost of these therapies which lead us to compare cost of these therapies. In a country like India where cost is a greater parameter to decide therapy a cost effective therapy carries a better compliance and effectiveness as compared to an expensive therapy like Rituximab. In the study we observed DCPtherapy was three times cheaper than Rituximab


2021 ◽  
Vol 12 (5) ◽  
pp. 275-277
Author(s):  
Kriti Sareen ◽  
Fozia Sultana ◽  
Zabin Mirza ◽  
Kalpna Thakur ◽  
Ekta Parmar ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document